Future Market Insights has announced the addition of the “Pancreatic Cyst Diagnostics Market: : Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029" report to their offering.
Valley Cottage, NY -- (SBWIRE) -- 06/27/2019 -- The growth of sac-like pocket filled with fluid on the pancreas is called pancreatic cyst. Majority of pancreatic cyst is non-cancerous while in a few cases it may develop benign cancer. Pancreatic cyst diagnostic test is done by using imaging technology. There are four ways to perform the pancreatic cyst diagnostic viz, CT scan, MRI scan, and endoscopic ultrasound. Prior to all this test, medical history of the patient is studied to verify the previous abdominal injury. The CT scan for pancreatic cyst diagnostic provides detail information about the structure and size of the pancreatic cyst. While the pancreatic cyst diagnostic test by MRI scan helps to understand the risk of cancer. Endoscopic ultrasound can also be performed to analyse the risk of cancer from the pancreatic cyst.
Pancreatic Cyst Diagnostics Market: Drivers and Restraints
Rising prevalence of pancreatic cancer throughout the globe is the key factor propelling the growth of the pancreatic cyst diagnostics market over the forecast period. The increase in alcohol consumption and smoking is the key factor behind rising patient pool suffering from the pancreatic cyst. Also, the recent launches of more improved MRI and CT scanners is propelling the demand for pancreatic cyst diagnostics market. Also, the rising number of awareness. On the other hand, lack of healthcare infrastructure and shortage of skilled medical professional in the under developing economies may responsible for the sluggish growth of pancreatic cyst diagnostics market over the next decade.
Download sample copy of this report:
Pancreatic Cyst Diagnostics Market: Segmentation
The global pancreatic cyst diagnostics market is classified on the basis of product type, indication end user and geographic region.
Based on product type, pancreatic cyst diagnostics market is segmented into following:
Based on cyst type, pancreatic cyst diagnostics market is segmented into following:
Intraductal Papillary Mucinous Neoplasm
Mucinous Cystic Neoplasm
Solid Pseudopapillary Neoplasm
Based on end user, pancreatic cyst diagnostics market is segmented into following:
Academic and Research Institutes
Pancreatic Cyst Diagnostics Market: Overview
The pancreatic cyst diagnostics market is expected to show robust growth over the forecast period due to the rising number of cases of pancreatic cancer due to the pancreatic cyst. According to a few studies, approximately 2.5% people are suffering from pancreatic cyst are also suffering from pancreatic cancer. As per recent data by GLOBOCAN, around half of the million people in the world are suffering from pancreatic cancer in 2017. By product type, MRI scanner will be the dominating segment though MRI scanner can perform the pancreatic efficiently and also determine the probability of pancreatic cancer more precisely. Intraductal papillary mucinous neoplasm most common type of pancreatic cyst, hence this segment is expected to gain the major revenue share for pancreatic cyst diagnostics market by cyst type. Among all end user hospital segment will dominate the market in term of revenue which is then followed by the diagnostic centers. While specialized clinic segment is expected to grow at a greater pace than other segments by end user for pancreatic cyst diagnostics market over the forecast period.
Pancreatic Cyst Diagnostics Market: Regional Overview
The high healthcare infrastructure in the U.S. And Canada is the key reason behind the leading share of North America for pancreatic cyst diagnostics market in term of revenue. After North America, Europe, and East Asia region is expected to gain the revenue share of the pancreatic cyst diagnostics market. High awareness among the people about pancreatic cancer in the U.K., Germany, France, Italy, Spain other European countries is the key factor behind the growth of the pancreatic cyst diagnostics market in Europe. South Asia and East Asia region is expected to show rapid growth over the forecast period for the pancreatic cyst diagnostics market due to the rising prevalence of pancreatic cancer in India, China, and Japan. Middle & Africa and Latin America are expected to show the delayed growth for the pancreatic cyst diagnostics market owing to the lack of healthcare infrastructure in these geographies.
Download table of contents with figures & tables:
Pancreatic Cyst Diagnostics Market: Key Players
Examples of some of the market participants in pancreatic cyst diagnostics market identified across the value chain include Carestream Health, Esaote SpA., GE Healthcare, Hitachi Medical System, Hologic, Inc., Fujifilm Holdings Corporation, Koninklijke Philips N.V., SAMSUNG, Siemens AG, Toshiba Corporation, Bruker Corporation, Carl Zeiss AG, Eaton and others.